[
  {
    "ts": "2025-11-06T05:35:40+00:00",
    "headline": "ResMed’s Q3 Earnings Call: Our Top 5 Analyst Questions",
    "summary": "ResMed’s third quarter results aligned with Wall Street’s revenue expectations, while its non-GAAP earnings per share moderately outpaced consensus. Management attributed the quarter’s performance to robust demand for both devices and masks, particularly in the U.S., Canada, and Latin America, where mask resupply programs and new product launches drove growth. CEO Michael Farrell highlighted the contribution of recent acquisitions and continued investment in digital health, noting, “Our global t",
    "url": "https://finance.yahoo.com/news/resmed-q3-earnings-call-top-053540077.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "6dc03ea1-a97e-344c-b85f-a705e70e12f4",
      "content": {
        "id": "6dc03ea1-a97e-344c-b85f-a705e70e12f4",
        "contentType": "STORY",
        "title": "ResMed’s Q3 Earnings Call: Our Top 5 Analyst Questions",
        "description": "",
        "summary": "ResMed’s third quarter results aligned with Wall Street’s revenue expectations, while its non-GAAP earnings per share moderately outpaced consensus. Management attributed the quarter’s performance to robust demand for both devices and masks, particularly in the U.S., Canada, and Latin America, where mask resupply programs and new product launches drove growth. CEO Michael Farrell highlighted the contribution of recent acquisitions and continued investment in digital health, noting, “Our global t",
        "pubDate": "2025-11-06T05:35:40Z",
        "displayTime": "2025-11-06T05:35:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/f0a7c7170a2138eadddc0bd971521e8f",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "RMD Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y_ZPYxj5FiW9M_.8e6GQLA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/f0a7c7170a2138eadddc0bd971521e8f.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5trFkIGP9y6dlfK13.L8Xw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/f0a7c7170a2138eadddc0bd971521e8f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/resmed-q3-earnings-call-top-053540077.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/resmed-q3-earnings-call-top-053540077.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]